Grade My Investments
HomeFree Stock Grades › SGHT

Sight Sciences, Inc. (SGHT) Stock Grade

SGHT · Healthcare

B+
Grade updated: July 18, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$413.5M
P/E Ratio
Revenue Growth (YoY)
-3.1%
Net Margin
-49.7%
Return on Equity
Dividend Yield
None

About Sight Sciences, Inc.'s fundamentals

Sight Sciences is a medical device company with a market capitalization of $413.5 million that is currently unprofitable, operating at a net margin of -49.7% and reporting a net loss in its latest annual statement. The company experienced a slight revenue decline of 3.1% year-over-year, indicating contraction in its top line. With no dividend yield and negative profitability metrics, the company is in an early-stage or turnaround phase typical of many healthcare device manufacturers still scaling operations.

Track SGHT free — no credit card required. Live grade + monthly AI report →